The efficacy and safety of anti-interleukin-6 receptor monoclonal blockade in a renal transplant patient with Castleman disease: early post-transplant outcome

The efficacy and safety of anti-interleukin-6 receptor monoclonal blockade in a renal transplant patient with Castleman disease: early post-transplant outcome

Abstract Background Multicentric Castleman disease (MCD) is an uncommon lymphoproliferative disease characterized by systemic inflammatory reactions associated with the dysregulated production of interleukin-6 (IL-6). In patients with MCD, renal involvement is uncommon, with only one report publishe...

Full description

Bibliographic Details
Main Authors: Masatoshi Matsunami, Yoshifumi Ubara, Keiichi Sumida, Yoichi Oshima, Masahiko Oguro, Kazuya Kinoshita, Kiho Tanaka, Yuki Nakamura, Keiichi Kinowaki, Kenichi Ohashi, Takeshi Fujii, Takuro Igawa, Yasuharu Sato, Yasuo Ishii
Format: Article
Language:English
Published: BMC 2018-10-01
Series:BMC Nephrology
Subjects:
Castleman disease
Kidney transplantation
Tocilizumab
IL-6
IgA nephropathy
Online Access:http://link.springer.com/article/10.1186/s12882-018-1065-4

Internet

http://link.springer.com/article/10.1186/s12882-018-1065-4

Similar Items